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Background: A rapid, non-invasive, and inexpensive point-of-care (POC) diagnostic for malaria followed by
therapeutic intervention would improve the ability to control infection in endemic areas.
Methods: A semi-nested PCR amplification protocol is described for quantitative detection of Plasmodium
falciparum and is compared to a traditional nested PCR. The approach uses primers that target the P. falciparum
dihydrofolate reductase gene.
Results: This study demonstrates that it is possible to perform an uninterrupted, asymmetric, semi-nested PCR assay
with reduced assay time to detect P. falciparum without compromising the sensitivity and specificity of the assay
using saliva as a testing matrix.
Conclusions: The development of this PCR allows nucleic acid amplification without the need to transfer amplicon
from the first PCR step to a second reaction tube with nested primers, thus reducing both the chance of
contamination and the time for analysis to < two hours. Analysis of the PCR amplicon yield was adapted to lateral
flow detection using the quantitative up-converting phosphor (UCP) reporter technology. This approach provides a
basis for migration of the assay to a POC microfluidic format. In addition the assay was successfully evaluated with
oral samples. Oral fluid collection provides a simple non-invasive method to collect clinical samples.
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Malaria, a mosquito-borne disease caused by parasites of
the Plasmodium genus, exacts a global toll of at least
216 million clinical cases and 655,000 deaths annually of
which ~85% are children under the age of five [1].
Currently, diagnosis of malaria is based on four different
approaches: microscopy, antigen detection using immuno-
chromatographic rapid diagnostic tests (RDTs), malaria
antibody detection, and nucleic acid-based assays. Micros-
copy remains the “gold standard” method for laboratory
confirmation of malaria, and involves examination of thick
and thin blood films stained with Romanowsky stain
(mainly Giemsa or Field stain). However, microscopic* Correspondence: daniel.malamud@nyu.edu
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distribution, and reproduction in any mediumdiagnosis of malaria is dependent on the personnel
performing and interpreting the results, and requires
specialized equipment that is difficult to support in re-
mote areas lacking a reference laboratory. Moreover, low
parasitaemia, especially in asymptomatic subjects, is not
detected by microscopy.
To alleviate some of the difficulties of microscopy-based
diagnosis of malaria, RDTs that detect parasite-specific an-
tigens were developed [2]. The most commonly targeted
malaria antigens are Plasmodium falciparum histidine-
rich protein-2 (pfHRP2) and Plasmodium lactate dehydro-
genase (pLDH) [3-6]. RDTs offer ease of operation, a
timely diagnosis, and do not require trained personnel or
special equipment [2,7]. However, they are relatively ex-
pensive and prone to false-positive responses due to per-
sistence of pfHRP2 antigen in blood for up to two weeks
after the parasite is cleared [2,8]. Also, the relatively lowed Central Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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tempting malaria pre-elimination, where detection and
treatment of low-grade reservoir infections is required for
effective elimination of infection [9].
In recent years, a molecular approach has been used
to detect Plasmodium nucleic acids circulating in blood,
saliva, and other body fluids [10-13]. Polymerase chain
reaction (PCR) is more accurate and sensitive than mi-
croscopy and RDTs, detects low-grade parasitaemia and
is indicative of active infection [14,15]. Detection and
amplification of Plasmodium DNA is generally performed
using nested PCR, a two-step procedure in which the
product of the initial reaction is amplified a second time
with a new pair of “inner” primers that hybridize to the
dihydrofolate reductase (DHFR) gene located within the
previously amplified region [10,16]. Nested PCR typically
requires transfer of a small amount of product from the
first step to serve as template for the second amplification
in a second tube. The requirement to transfer PCR-
amplified products dramatically increases the risk of
carry-over and environmental contamination. Moreover,
the two rounds of amplification may require up to six
hours to complete. Investigators have attempted to de-
velop single-tube nested or closed-tube nested PCRs to
eliminate the transfer procedure and thus minimize
contamination, reducing false-positive results, and main-
taining high sensitivity [17]. However, to date, despite the
high sensitivity and low risk of carry-over contamination
associated with a single-tube nested PCR, this technique is
susceptible to inhibition by inappropriate sample prepar-
ation [17]. Real-time PCR also minimizes contamination,
but nesting is needed to optimize the limit of detection
(LOD) [18,19]. Also, the common use of SYBR Green
DNA-intercalating dye in many real-time PCR kits, which
binds any double strand DNA, makes the assay less specific
and prone to false-positive results. Furthermore, the use of
specific fluorescent probes for certain types of qPCR, al-
though specific, are expensive which greatly diminishes
their routine use [20].
A generic platform [21-23] was developed to analyse
HIV and other pathogen-related antigens, antibody, and
nucleic acids in saliva or blood simultaneously by a com-
bination of RT-PCR and an immunoassay with detection
by up-converting phosphors (UCP) label and lateral flow
technology [21,24-26]. The UCP reporter converts photons
of lower energy infrared light into higher energy visible
light and is ultrasensitive since this unique process does
not demonstrate autofluoresence [27]. Using a similar ap-
proach an uninterrupted, asymmetric, semi-nested PCR
providing quantitative detection of a P. falciparum DNA
target with a significant reduction in overall assay time and
improved robustness with respect to reducing the probabil-
ity of contamination was developed. The system is ideal for
further development to a point-of-care (POC) device.Methods
Samples and instrumentation
DNA from P. falciparum laboratory clone 3D7 was pro-
vided by Professor Karen Day, New York University
School of Medicine. The 3D7 DNA was adjusted to a
working concentration of 270 ng/μl and used as positive
control for the PCR assays. Unstimulated whole saliva
samples (5 ml) were collected in the area surrounding the
Malaria Institute at Macha (MIAM, Choma, Zambia) from
patients tested positive for malaria by microscopy [11].
The specimens were transported to the Malaria Institute
at Macha laboratory within a few hours of collection,
where they were aliquoted into 1 ml amounts and stored
at −20°C. Ten-fold serial dilutions of P. falciparum NF54
culture, donated by Dr Godfree Mlambo, Johns Hopkins
Bloomberg School of Public Health, were used to deter-
mine the parasite detection threshold, and negative controls
lacking template were included to preclude contamination.
All amplifications were performed using a DNA engine
DYAD PCR (BioRad). Digital quantification of amplicon
from gel images employed ImageJ [28] or ImageQuant
software (ImageQuant, GE Healthcare Life Sciences,
Piscataway, NJ, USA).
Isolation of malaria DNA from saliva and dried blood
Whole saliva samples (1 ml) were centrifuged at
8,000 rpm for 3 min. Essentially all of the DNA was in
the pellet, which was then extracted using the crude cell
lysate protocol of the Qiagen DNAeasyW Blood and Tis-
sue kit (Qiagen, Valencia, CA, USA) according to the
manufacturer’s instructions and DNA eluted in 8 μl of
distilled H2O.
Whole blood samples were spiked with a titer of P.
falciparum parasite and then ~100 μl was dried on
Whatman filter paper. A Qiagen QIAamp DNA mini kit
was used to isolate parasite DNA from six 3-mm diameter
punches (Harris Punch) from the dried filter paper in a
total volume of 150 μl distilled H2O.
Primers used for PCR amplification reactions
The initial studies employed genus-specific primers
rPLU1/rPLU5 for the small ribosomal subunit that yields
a 1.6 kb fragment for first amplification (rPLU1: 50-
TCAAAGATTAAGCCATGCAAGTGA-30 and rPLU5:
50-CCTGTTGTTGCCTTAAACTCC-30). The inner species-
specific labelled primers for the second amplification
yielded a 205 bp fragment for P. falciparum were rFAL1
(Forward): 50-Digoxigenin-TTAAACTGGTTTGGGAAA
ACCAAATATATT-30 and rFAL2 (Reverse): 50- Biotin-
ACACAATGAACTCAATCATGACTACCCGTC-3
[10,16,29-31]. With these primers the LOD was only
1.35 ng of DNA. Subsequent experiments used a second
set of P. falciparum DHFR gene specific primers: U1 (For-
ward: 50 -GGAAATAAAGGAGTATTACCATG-30) and
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CA-30), which yields a 273 bp fragment in the primary
amplification. Inner primer U3 (Forward: 50-Digoxigenin-
GAAATGTATTTCCCTAGATATGgAATATT-30) and U4
(Reverse: 50-Biotin-ATTTATCCTATTGCTTAAAGGT-30)
[10,16,30-34] were used in the second round of amplifica-
tion and produced a 229 bp amplicon. For the semi-
nested asymmetrical PCR the U1 primer was labeled with
digoxigenin. The PfDHFR primers were adopted as they
attained superior detection threshold in parasite serial di-
lutions and in earlier work detecting P. falciparum from
human saliva samples [11]. The primers also flank DHFR
amino acid codon 108 for optional detection of anti-folate
drug resistance-associated mutations.
Molecular detection of Plasmodium falciparum
A gene-specific nested PCR protocol developed by Dr.
David Sullivan’s group [11] was used in a conventional
nested PCR as illustrated in Figure 1. To allow detection of
P. falciparum PCR amplicons by lateral flow, forward pri-
mer U3 and reverse primer U4 were synthesized with biotin
and digoxigenin haptens at their respective 50-ends. The
resulting biotin-digoxigenin tagged DNA amplicon was
bound to UCP reporter particles coated with mouse-anti
digoxigenin [35] and subsequently captured by an avidin
test line on nitrocellulose lateral flow strips. The UCP fluor-
escence signal was detected by interrogating the strips with
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Figure 1 Schematic of nested PCR (A) and semi-nested asymmetric PC
the first amplicon product.line UCP signals observed is proportional to the amount of
target molecule.
Nested PCR amplification
Conventional nested PCR for P. falciparum with the pri-
mer pair U1 and U2 yielding a 273 bp amplicon (Figure 1A)
was carried out as described by Mharakurwa et al. [11].
Using the 273 bp amplicon as a template, the second
round of PCR employed the nested primer pair U3 and U4
that amplifies a nested product specific for P. falciparum.
Briefly, both the first and second PCR amplifications were
carried out in a total volume of 25 μl consisting of 2 μl tem-
plate (0.5 μl for standard lab clone 3D7); 0.25 μM of each
primer; 1.5 mM magnesium chloride; 0.2 mM dNTPs; 1X
PCR Buffer; and 1U Taq polymerase. The nested PCR amp-
lification required a total of six hours to complete both the
first and second amplifications. Using conventional nested
PCR (Figure 1A), an initial amplification was performed
using primers U1 and U2 and the following programme:
94°C/2 min; (94°C/45 sec; 43°C/45 sec; 65°C/1 min) × 25 -
cycles after which 1.6 μl was transferred to a second tube
with fresh reagents and inner primers U3 and U4. Amplifi-
cation using the same program was performed for an add-
itional 25 cycles for a total run time of ~3.5 hours.
Semi-nested asymmetric PCR
Unlike conventional nested PCR, the semi-nested asym-
metric PCR (Figure 1B) was performed in a single tube,252 bp
Target
Sequence
bined “Inner & Outer” 
Primer Sets
U2 [0.1 µM)





 Semi-nested Asymmetrical PCR
Amplicon
Ta1=58.3˚C for 9 cycles
Ta2=40.1˚C for 25 cycles
R (B). Note that the semi-nested PCR does not require a transfer of
Figure 2 (See legend on next page.)
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Figure 2 PCR titration of genomic DNA using the genus specific primers. A) The schematic outlines the strategy for UCP detection. B) UCP
detection of digoxigenin-biotin labelled amplicon generated from a serial dilution of P. falciparum DNA using semi-nested PCR. The equivalent #
parasites per reaction were 38084, 3408, 1704, 852, 426, 213, 107, 53, 27, 13, 7, and 3, which corresponds to Lane numbers 1 through 12 on the
image of the agarose gel. The insert is the ethidium bromide stained agarose gel (2%), which confirms the resulting amplicon products as a
function of the serial dilution of Plasmodium falciparum DNA. Each lane contained 18 μl of the PCR product. The intensity of the phosphorescent
UCP reporter particles was measured through excitation at 980 nm and emission at 455 nm.
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lowing programme: 94°C/2 min; (94°C/45 sec; 58°C/
50 sec; 65°C/1 min) x 9 cycles; 94°C/2 min; 94°C/45 sec;
40°C/50 sec; 65°C/1 min) x 25 cycles; 65°C, 2 min with a
total running time of ~1.5 hours. The single-tube semi-
nested PCR reaction, which generates a 252 bp amplicon,
was performed in a total volume of 20 μl containing 8 μl
template DNA; 0.45 μM, 0.1 μM and 0.3 μM, respectively
of primers U1, U2 and U4; 1X PCR buffer, 0.2 mM dNTP;
2U Taq polymerase.
Lateral flow assay adaptation
The PCR-generated digoxigenin-biotin labelled amplicon
was analysed as previously described [35]. Briefly, 1 μl of
amplified PCR product was mixed with 100 ng mouse-
anti digoxigenin-UCP conjugate dispersed in 100 μl of lat-
eral flow buffer (100 mM Hepes pH 7.2, 270 mM NaCl,
1% (w/v) BSA, 0.5% (v/v) Tween 20) and incubated in a
thermal shaker (1,000 rpm, 37°C) for 30 min. The mixture
was then added to a microtiter plate well containing a lat-
eral flow nitrocellulose strip with a “test” line consisting of




































Figure 3 UCP detection analysis of clinical malaria saliva samples usin
assay: UCP reporter was used to detect the biotin-digoxigenin labelled amp
Parasite concentrations were determined using thick film microscopy of suThe avidin test line captures the biotin labelled PCR
amplicons bound to the UCP reporter as it flows on the
lateral flow strip and the unbound UCP binds to the dis-
tal control line comprised of mouse anti-digoxigenin
antibody. Following immunochromatography, the strips
were dried and analysed for UCP using a Packard Fluoro
Count™ adapted with a 980 nm Infrared Opto Power
Corp laser [27].
Results
The detection threshold of the conventional malaria-nested
PCR was determined using a ten-fold serial dilution series
of P. falciparum NF54 culture samples ranging from 800 to
0.0.08 pg DNA per reaction (~3.4X104 to ~3 parasites/reac-
tion). The amplicons generated were detected by agarose
gel electrophoresis and lateral flow UCP detection (Figure 2B).
Figure 2A provides a schematic of the binding events oc-
curring at the respective Test and Control lines for lateral
flow detection. Negative controls lacked reactivity.
DNA was extracted from saliva specimens (1 ml) ob-
tained from negative and positive malaria patients with
low-grade parasitaemia (ranging from microscopy negativeSaliva Sample
3 4 5 6 7 8
g the semi-nested asymmetric PCR protocol. UCP lateral flow
licons generated using the single-step PCR amplification protocol.
bject blood. The threshold is indicated as a horizontal dashed line.
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200 μl, and 8 μl of the eluted DNA template amplified by
the semi-nested PCR. The results obtained by gels and
UCP LF assay of the clinical samples were concordant
with the subject’s known malaria status and level of para-
sitaemia (Figure 3). These experiments successfully dem-
onstrate proof-of-principle for uninterrupted single-tube
PCR for detection of plasmodium DNA with both P.
falciparum-positive laboratory control and clinical sam-
ples. In addition it is possible to utilize the semi-nested
PCR approach for sensitive detection of P. falciparum in
dried blood spots (Figure 4).Figure 4 LOD of parasite DNA using semi-nested PCR from six
3-mm diameter stored dried blood spots. A) Amplicons are
visualized in a 1.5% agarose gel stained with ethidum bromide. NC1
refers to a blood sample that was not spiked with any parasite and
went through an identical DNA isolation and amplification to the
rest the experimental samples. NC2 refers to PCR master mix to
which PCR grade water was substitutes for eluted DNA as a control
for contaminants in PCR reagents. B. Graph of the relative pixel
density of the amplicon as a function of the parasite concentration.The basis for the single-tube amplification is that the
first nine annealing cycles favour efficient amplification
of the primary U1/U2 product, which subsequently
serves as template for the secondary U1/U4 amplicon,
both during the primary and secondary reactions. The
252 bp amplicon is most efficiently amplified at the
annealing temperature of the subsequent 25 cycles. The
concentration of U1 primer is highest, as it is used both
in the primary and secondary reactions; U2 has the low-
est concentration for the initial short (nine) primary
annealing cycles, which minimizes competition with the
secondary primer U4; and U4 has a standard primer
concentration to serve in the 25 secondary cycles. In this
approach, the primary amplicon rate of production gets
a head start, but then slows as it provides template for
the second amplification.
Discussion
The current experiments provide proof of principle for a
malaria diagnostic that combines a quick semi-nested
asymmetric PCR combined with a UCP lateral flow assay
for the detection of P. faciparum DNA in saliva samples. A
semi-nested asymmetric PCR that can detect P. falciparum
DNA with a lower limit of detection comparable to that of
the conventional nested PCR with both P. falciparum
standard DNA as well as with saliva samples (Figure 3) was
demonstrated. The sensitivity threshold for the original
nested PCR strategy was equivalent to ~1-10 parasite/μl of
peripheral blood sample [29,36], which surpasses routine
microscopy (40 parasites/μl) and RDTs (100 parasites/μl)
(Figure 4). The more specific gene-directed primers were
chosen to pursue the semi-nested PCR. The first step in
the semi-nested PCR is at high annealing temperature,
which is more specific, while the second step is at a lower
temperature and less specific. PCR performed at low spe-
cific conditions (low Ta) would generate non-specific prod-
ucts and/or false positives. The developed semi-nested
asymmetric PCR minimizes the risk for contamination
since it does not require sample carry-over to a second
tube before starting the amplification of the nested frag-
ment. Moreover, the semi-nested PCR only takes ~1.5
hours, which is ~40% of the total time taken to run con-
ventional nested PCR [10,11]. Furthermore, in comparison
to gel electrophoresis, LF allows a more convenient quanti-
tative analysis suited for point-of-care applications. With a
limited number of clinical saliva samples the feasibility of
the assay was demonstrated to correctly identify positive
samples. Additional studies are required to conclude
whether this assay is a good point-of-care alternative for
testing saliva-based samples rather than the conventional
nested PCR developed for analysing blood-based samples
in a dedicated diagnostic laboratory. The development of
automated microfluidic devices capable of performing the
above-described analysis of either a saliva or blood sample
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for genotyping mosquitoes has been described by Liu et al.
[38].
Conclusions
This study demonstrates a semi-nested asymmetric PCR
in a compressed time frame to detect P. falciparum DNA.
The resulting digoxigenin-biotin tagged DNA amplicons
are quantified using lateral flow and the sensitive UCP
reporter technology. The assay reduces the chance of
cross-contamination and can be readily configured as a
POC assay using fresh or dried blood or saliva. The total
assay time (including analysis) is reduced as compared to
the conventional nested PCR approach with gel analysis.
Integration of the new test into a microfluidic format
using oral fluid has the potential to be used as an efficient
non-invasive tool for POC applications, overcoming the
limitations of microscopy and RDTs in detecting low-
grade reservoirs of infection.
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